Аннотация:
The current population is characterized by a high prevalence of risk factors for the development of chronic kidney disease: hypertension, diabetes, obesity, metabolic syndrome, physical inactivity, smoking. The development of severe complications and a close connection with potentially fatal cardiovascular disorders make this disease a socially and economically significant problem. Treatment of chronic kidney disease in advanced stages belong to nephrologist duties. However, the success of preventive interventions depends on the time of their onset, which makes it relevant to identify the disease. The use of nephroprotective approaches by physicians of different specialties (general practitioners, cardiologists, gerontologists, nephrologists, endocrinologists) can significantly improve the prognosis of both those at risk of developing renal dysfunction and the existing disease. The review presents data on the clinical and laboratory efficacy of angiotensin-renin blocker use, as well as
Ключевые слова:
Amlodipine; Angiotensin receptor blockers; Arterial hypertension; Chronic kidney disease; Fixed combinations; Nephroprotection
amlodipine; angiotensin receptor antagonist; calcium antagonist; irbesartan; antihypertensive therapy; Article; drug efficacy; human; hypertension; kidney failure; renal protection
Подзолков В. И. Валерий Иванович 1948-
Брагина А. Е. Анна Евгеньевна 1973-
Ишина Т. И. Татьяна Ивановна 1967-
Брагина Г. И. Галина Ивановна 1951-
Васильева Л. В.
Podzolkov V. I. Valerij Ivanovich 1948-
Bragina A. E. Anna Evgenyevna 1973-
Ishina T. I. Tat`yana Ivanovna 1967-
Bragina G. I. Galina Ivanovna 1951-
Vasilyeva L. V.
Nephroprotective strategy in the treatment of hypertension as a modern general medical problem
Текст визуальный непосредственный
Российский кардиологический журнал
ООО "Силицея-Полиграф"
Т. 23, Вып. 12 С. 107-118
2018
Статья
Amlodipine Angiotensin receptor blockers Arterial hypertension Chronic kidney disease Fixed combinations Nephroprotection
amlodipine angiotensin receptor antagonist calcium antagonist irbesartan antihypertensive therapy Article drug efficacy human hypertension kidney failure renal protection
The current population is characterized by a high prevalence of risk factors for the development of chronic kidney disease: hypertension, diabetes, obesity, metabolic syndrome, physical inactivity, smoking. The development of severe complications and a close connection with potentially fatal cardiovascular disorders make this disease a socially and economically significant problem. Treatment of chronic kidney disease in advanced stages belong to nephrologist duties. However, the success of preventive interventions depends on the time of their onset, which makes it relevant to identify the disease. The use of nephroprotective approaches by physicians of different specialties (general practitioners, cardiologists, gerontologists, nephrologists, endocrinologists) can significantly improve the prognosis of both those at risk of developing renal dysfunction and the existing disease. The review presents data on the clinical and laboratory efficacy of angiotensin-renin blocker use, as well as